Cancer cells impair monocyte-mediated T-cell activation by disrupting inflammatory pathways in the tumor microenvironment.
Treated mice also had reduced tumor growth when injected with melanoma cells, and they produced more T cells in response to ...
Receptors are cellular components that trigger internal changes based on external signals. Researchers have built a new synthetic receptor with incredibly broad potential to program cell activity, ...
Macrophages, immune cells typically known for fighting infections, have been discovered to play a vital role in controlling movement and linking neural activity with metabolic demands.
Researchers have built a synthetic receptor with broad potential to program cell activity, including immune response and ...
Immune dysfunction is a condition in which the immune system doesn't work as it should. It can be underactive, which means ...
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
Yale researchers have made an unexpected discovery—turncoat T cells that help a tumor evade other cancer-fighting immune T ...
PHILADELPHIA, PA — The Wistar Institute, led by Dr. David B. Weiner, has announced successful preclinical tests of a ...
Every winter, influenza returns with a new variant. People who have previously been infected with or vaccinated against flu ...
TARA-002 demonstrates 72% six-month landmark complete response rate and 70% complete response rate at any time across BCG ...
Sponsored content Keeping your immune system in good working order is important for overall health. But it’s something many ...